Could a common pill ease the swelling of failing livers?
NCT ID NCT05726032
Summary
This study is testing whether empagliflozin, a medication typically used for diabetes, can help reduce dangerous fluid buildup in the abdomen (ascites) of people with advanced liver scarring (cirrhosis). Researchers will give the drug or a placebo to 20 patients for 14 days to see if it helps the body remove excess salt and water. The goal is to find a new way to manage this serious complication and improve kidney function in these patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yale University
RECRUITINGNew Haven, Connecticut, 06510, United States
Contact
Conditions
Explore the condition pages connected to this study.